< Back to previous page
Researcher
An Goris
- Disciplines:Immunology
Affiliations
- Laboratory for Neuroimmunology (Lab)
Member
From1 Jan 2012 → Today - Research Group Experimental Neurology (Division)
Member
From1 Apr 2004 → 31 Dec 2011 - Immunobiology (Rega Institute) (Lab)
Member
From1 Oct 1999 → 31 Mar 2004
Projects
1 - 10 of 42
- Multiple sclerosis immunogenetics: moving to multimodal single-cell resolutionFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Elucidating the role of Epstein-Barr virus in multiple sclerosis pathophysiology.From1 Oct 2022 → TodayFunding: FWO fellowships
- Applying multivariate longitudinal models and AI algorithms to identify multi-point outcomes in progressive MSFrom1 Jul 2022 → 30 Apr 2023Funding: Foreign private sponsor - undefined
- Belgian Genome BiobankFrom1 May 2022 → TodayFunding: FWO Large scale research infrastructure
- Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometryFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- In-depth characterization of natural killer cell heterogeneity in multiple sclerosis.From1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- Using machine learning to model the prognosis of multiple sclerosis patientsFrom27 Sep 2021 → TodayFunding: FWO Strategic Basic Research Grant
- The Role of Natural Killer Cells in Multiple SclerosisFrom1 Sep 2021 → TodayFunding: FWO fellowships
- Multiple sclerosis immunogenetics: moving to multi-omics single-cell resolutionFrom1 Sep 2021 → TodayFunding: FWO fellowships, Foreign private sponsor - undefined
- Early microglial activation contributes to long-term progression in MSFrom1 Jul 2021 → 30 Jun 2023Funding: Foreign private sponsor - undefined
Publications
1 - 10 of 110
- A targeted sequencing extension for transcript genotyping in single-cell transcriptomics(2023)
Authors: Margaux David, An Goris, Bénédicte Dubois
- Exploring genetic clustering of severity markers to identify groups with reduced heterogeneity in multiple sclerosis(2023)
Authors: An Goris
Pages: 479 - 480 - The role of glial cells in sALS and C9orf72 HRE-mediated ALS(2023)
Authors: Pegah Masrori, Philip Van Damme, An Goris
- Locus for severity implicates CNS resilience in progression of multiple sclerosis(2023)
Authors: Bénédicte Dubois, An Goris
Pages: 329 - 331 - Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13, 4198.(2023)
Authors: Jeroen Blommaert, Charlotte Sleurs, Sigrid Hatse, An Goris, Michel Koole, Ann Smeets, Koen Van Laere, Stefan Sunaert, Sabine Deprez
Pages: 3091 - Genetics of multiple sclerosis: lessons from polygenicity(2022)
Authors: An Goris
Pages: 830 - 842 - Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies(2022)
Authors: Marijne Vandebergh, Bénédicte Dubois, An Goris
Pages: 4565 - 4574 - Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis: A Mendelian Randomization Study(2022)
Authors: Marijne Vandebergh, Bénédicte Dubois, An Goris
- From susceptibility to heterogeneity in multiple sclerosis: insights from genetic epidemiology(2022)
Authors: Marijne Vandebergh, An Goris, Bénédicte Dubois
- Natural killer cells in multiple sclerosis: entering the stage.(2022)
Authors: Jarne Beliën, An Goris, Patrick Matthys